PHS
SGHT icon

PFM Health Sciences’s Sight Sciences SGHT Stock Holding History

PFM Health Sciences’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-227,692
Closed -$1.45M – 96
2022
Q3 		$1.45M Sell
227,692
-548,589
-71% -$4.64M 0.05% 82
2022
Q2 		$6.98M Buy
+776,281
New +$6.83M 0.27% 69
2021
Q4 		– Sell
-483,538
Closed -$11M – 85
2021
Q3 		$11M Buy
+483,538
New +$15.9M 0.32% 58

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PFM Health Sciences's SGHT Position: Q4 2022 in Review

PFM Health Sciences sold out of Sight Sciences (SGHT) in Q4 2022, closing a stake of 227,692 shares — an estimated $1.45M sold.

PFM Health Sciences first reported a position in SGHT in Q3 2021 and held it in 3 quarters. The position peaked at $11M in Q3 2021. 66 funds tracked by Wall St. Rank hold SGHT as of Q4 2022.

  • PFM Health Sciences reported no remaining Sight Sciences position as of Q4 2022 after selling out during the quarter.
  • PFM Health Sciences sold 227,692 Sight Sciences shares in Q4 2022, an estimated $1.45M.
  • PFM Health Sciences first reported a position in Sight Sciences in Q3 2021 and held it in 3 quarters.
  • PFM Health Sciences's Sight Sciences position peaked at $11M in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2022.

Based on PFM Health Sciences's 13F filing for Q4 2022, filed 14 Feb 2023.